Defunct Company
Total Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
1,412
NCT01719133
Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 29, 2008
Completion: Jun 30, 2008
NCT01728519
Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen
Phase: Phase 1/2
Start: Aug 31, 2008
Completion: Jul 31, 2012
NCT01720251
Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy
Phase: Phase 2
Start: Oct 31, 2012
Completion: Sep 30, 2013
NCT02143583
Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment
Phase: N/A
Start: Feb 28, 2014
Completion: Jul 31, 2014
NCT02271009
Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC
Start: Oct 31, 2014
Completion: May 31, 2015
NCT02943720
ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen
Start: Sep 30, 2016
Completion: Oct 31, 2017
NCT05963308
Promoting Sustainable Return to Work Among Employees on Sick Leave Due to a Mental Health Condition: Evaluation of the HealthyMinds Online Group Intervention
Role: Collaborator
Start: Mar 6, 2023
Completion: Mar 1, 2025
NCT06962891
Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease
Start: May 2, 2023
Completion: May 1, 2026